Clinical trial
HEALEY ALS Platform Trial - Regimen D Pridopidine
NCT04615923 is registered in ClinicalTrials.gov with Merit E. Cudkowicz, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HEALEY ALS Platform Trial - Regimen D Pridopidine
- Lead sponsor
- Merit E. Cudkowicz, MD
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- December 18, 2020
- Completion date
- July 14, 2022
- Enrollment
- 163 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.